Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × edoxaban × Clear all

Phase

Status

Completed 6 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1 Neoplasms 1

Interventions

Cisplatin 112 Carboplatin 110 Drug Therapy 108 Oxaliplatin 97 Bevacizumab 90 Capecitabine 89 Paclitaxel 82 Radiotherapy 80 Gemcitabine 78 Cyclophosphamide 78 pembrolizumab 77 tislelizumab 75 Specimen Handling 63 Fluorouracil 59 toripalimab 58 Docetaxel 54 Injections 52 sintilimab 51 Magnetic Resonance Spectroscopy 51 Surgical Procedures, Operative 50 130-nm albumin-bound paclitaxel 45 Biopsy 42 Leucovorin 41 fludarabine 38 Standard of Care 38 Pemetrexed 38 Immune Checkpoint Inhibitors 38 anlotinib 37 Radiosurgery 37 lenvatinib 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06149533 2023-11-29

Thrombosis

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Not yet recruiting

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡